Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

324.71 +0.48 (+0.15%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Here's Why Biohaven Pharmaceutical Is Soaring Today
Preliminary sales figures for the company's new migraine drug were much better than expected. 
Via The Motley Fool
Exposures Product Safety
Biohaven Stock Hits Record High As Migraine Drug Trounces Quarterly Forecasts
Biohaven crushed Wall Street's expectations for second-quarter sales of migraine drug Nurtec on Tuesday, leading BHVN stock to pop. 
Via Investor's Business Daily
Is Eli Lilly a Better Alzheimer's Stock Than Biogen?
An unusually lenient FDA is a knife that cuts both ways for Biogen. 
Via The Motley Fool
Exposures Product Safety
Eli Lilly, Boehringer Ingelheim Tout Heart Failure Win For Jardiance
Boehringer Ingelheim and Eli Lilly And Co (NYSE: LLY) have announced the topline results from the EMPEROR-Preserved Phase 3 trial of Jardiance (... 
Via Benzinga
Lilly Invests In MiNA To Fund Protein-Upregulating RNA Programs
Eli Lilly And Co (NYSE: LLY) is set to invest $15 million in its small activating RNA (saRNA) partner, MiNA Therapeutics. The investment comes two months... 
Via Benzinga
Where Eli Lilly Stands With Analysts
Analysts have provided the following ratings for Eli Lilly (NYSE: 
Via Benzinga
Thinking About Buying Stock Or Options In Walgreens, Enphase Energy Or Eli Lilly?
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I... 
Via Benzinga
Eli Lilly's Debt Overview
Over the past three months, shares of Eli Lilly (NYSE:LLY) increased by 26.91%. Before having a look at the importance of debt, let us look at how much debt Eli Lilly has.... 
Via Benzinga
Lundbeck Out Licenses Flopped Alzheimer's Drug In Wake Of Biogen's Controversial Success With Aducanumab
Privately-held Denovo Biopharma LLC has in-licensed global rights for idalopirdine from H. Lundbeck A/S (OTC: HLUYY) for all indications. The deal... 
Via Benzinga
10 Biggest Price Target Changes For Friday
Credit Suisse raised the price target for Capital One Financial Corporation (NYSE: 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive... 
Via Benzinga
Good Medicine at Bargain Prices
The pandemic has provoked a rethinking of pharma-biotech in our society. 
Via Talk Markets
2 Unstoppable Stocks to Buy No Matter What Happens in the Second Half of the Year
These two pharma companies can weather whatever storm is coming our way. 
Via The Motley Fool
EC Selects Antibody Therapies, Arthritis Drug As Preferred COVID-19 Meds: Reuters
The European Commission (EC) picked four antibody treatments and a repurposed Eli Lilly And Co's (NYSE: LLY) rheumatoid arthritis drug for an initial... 
Via Benzinga
Exposures COVID-19
Eli Lilly To Look For Ways To Cut Insulin Costs After Walmart Debut: CNBC
Eli Lilly And Co (NYSE: LLY) CEO David Ricks said he welcomes new competition from Walmart Inc (NYSE: WMT) even as the retailer undercuts the company's insulin... 
Via Benzinga
Danaher Stock Rises To Fresh High; Alderon Acquisition Will Expand DNA Portfolio
Danaher stock rose June 18 after it said it's buying Aldevron, which makes DNA and mRNA, a component in Covid19 vaccines, for $9.6 billion. 
Via Investor's Business Daily
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big... 
Via Benzinga
Exposures Product Safety
Stock Market Rally Revs To New Highs; Nike, Google, FedEx, Eli Lilly, Amazon In Focus: Weekly Review
The Nasdaq and S&P 500 hit highs as the stock market rally perked up, helped by a Biden infrastructure deal. Nike soared on earnings. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
45 Biggest Movers From Yesterday
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads... 
Via Benzinga
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
The Creeping Uptrend Continues with New Highs - Looking Beneath the Headlines
The Financial Sector caught a persistent bid today which boosted the small-cap Russell 2000 index and IWM. 
Via Talk Markets
Crazy Thursday
Today the US stock market went ballistic probably because of a higher joblessness level than expected. 
Via Talk Markets
These 2 Key Themes Are Driving the Stock Market to Record Highs
Find out what you need to know about all-time highs for stocks. 
Via The Motley Fool
Topics Economy Stocks
Exposures Economy US Equities
36 Stocks Moving In Thursday's Mid-Day Session
Gainers Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne... 
Via Benzinga
Lilly Stock Hits Record High On Key Alzheimer's Win, Looking To Follow Biogen
Eli Lilly's experimental Alzheimer's treatment snagged a key FDA designation on Thursday. LLY stock surged to a record high. 
Via Investor's Business Daily
Exposures Product Safety
Why Eli Lilly Stock Is Soaring Today
The company's promising Alzheimer's disease drug won FDA Breakthrough Therapy designation. 
Via The Motley Fool
Exposures Product Safety
Eli Lilly Jumps On Expedited Plans For Alzheimer's Drug, Biogen Falls
Eli Lilly announced that the Food and Drug Administration granted Breakthrough Therapy designation for donanemab, its investigational antibody therapy for Alzheimer's disease. 
Via Talk Markets
LLY Stock: The Alzheimer’s Drug News Sending Eli Lilly Higher Today
Eli Lilly (LLY) stock is soaring higher on Thursday following news of a decision from the FDA for its new Alzheimer's drug. 
Via InvestorPlace
Exposures Product Safety
PreMarket Prep Recap: The 4 Stocks Dennis Dick Bought Yesterday
On Wednesday’s PreMarket Prep, co-hosts Joel Elconin and Dennis Dick discussed the bullish chart setups in several tech stocks. ... 
Via Benzinga
Why Lilly Shares Are Moving Thursday
Eli Lilly and Company (NYSE: LLY) shares are advancing solidly Thursday following an update the company provided on its Alzheimer's program. What Happened: Lilly, which... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.